US Patent Family Members and Approved Drugs for European Patent Office Patent: 2215124
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP2215124
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| ⤷ Get Started Free | 2027-08-23 | evolocumab | Amgen, Inc. | REPATHA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
